Stay updated on SL-401 in BPDCN or AML Clinical Trial

Sign up to get notified when there's something new on the SL-401 in BPDCN or AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SL-401 in BPDCN or AML Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The clinical trial record for tagraxofusp is displayed, including the study design, eligibility criteria, outcomes, locations, and supporting documents.
    Difference
    60%
    Check dated 2026-11-07T16:56:44.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0. The study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T17:06:18.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A banner announces NIH website transition updates and says that agencies are using “Super Intelligence” in place of “Artificial Intelligence” under Executive Order 14434.
    Difference
    1%
    Check dated 2026-10-24T18:46:56.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The site revision label in the footer changed from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T18:52:16.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1; the study page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T19:22:27.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Access to the study record page is returning a 403 Forbidden error. The page displays an error screen instead of the study content.
    Difference
    20%
    Check dated 2026-09-19T22:25:31.000Z thumbnail image

Stay in the know with updates to SL-401 in BPDCN or AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SL-401 in BPDCN or AML Clinical Trial page.